GSK-LSD1

SKU:BHB21900022
Research Validated
Overview
Click light‑blue chips for details
GSK-LSD1 (CAS 1431368-48-7) is a LSD1 inhibitor. Relevant to Epigenetics research. Molecular formula C14H20N2, molecular weight 216.32 g/mol.
CAS Number 1431368-48-7
Molecular Weight 216.32 g/mol
Storage See Certificate of Analysis
Options selector
Catalog no. Size
HY-100546-50MG 50 mg
HY-100546-100MG 100 mg
HY-100546-250MG 250 mg
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 50 mg, 100 mg, 250 mg
  • Lead time: confirmed on inquiry for every option.
  • Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
  • Shipping: Room temperature in continental US; may vary elsewhere.
  • Upon receipt: store as stated on the Certificate of Analysis; contact us if you need the condition before ordering.
Field Specification
CAS no. 1431368-48-7
Applications
  • Functional Assay (In Vitro)
Molecular weight 216.32
Molecular formula C14H20N2
SMILES C1(N[C@H]2[C@H](C3=CC=CC=C3)C2)CCNCC1
Storage Refer to Certificate of Analysis (CoA) for storage conditions
Shipping Room temperature in continental US; may vary elsewhere.
Catalog no. (Mfr.) HY-100546
Main SKU BHB21900022
Inhibitors

Compound Overview

GSK-LSD1 is a chemical probe and inhibitor of LSD1. It reduces food intake and body weight and improves insulin sensitivity and glycemic control in mouse models of obesity, and it ameliorates NAFLD. GSK-LSD1 also inhibits SARS-CoV-2-triggered cytokine release in COVID-19 PBMCs and inhibits cancer growth and metastasis[1][2][3]. It has the molecular formula C14H20N2 and a molecular weight of 216.32 g/mol.

Physical & Chemical Properties

CAS Number 1431368-48-7
Molecular Formula C14H20N2
Molecular Weight 216.32 g/mol
SMILES C1(N[C@H]2[C@H](C3=CC=CC=C3)C2)CCNCC1
Signaling Pathway Epigenetics
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Shipping Room temperature in continental US; may vary elsewhere.

Literature Cited

Sources cited in this description. Peer-reviewed publications that used this product are listed under References.

[1]. Ramms B, et al. Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in Obesity. Diabetes. 2022 Dec 1;71(12):2513-2529.

[2]. Hong KS, et al. GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro. Signal Transduct Target Ther. 2020 Nov 17;5(1):267.

[3]. Alsaqer SF, et al. Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis. Oncotarget. 2017 Jul 27;8(43):73372-73386.

Safety

For Research Use Only. Not for use in diagnostic or therapeutic procedures, and not for human or veterinary use. Handle in accordance with your institution's chemical hygiene plan.

Q.Why is there no price listed?
A.Every size of this product is quoted on inquiry. Send us the size you need and we will come back with price and lead time.
Q.Can this be used in humans or for diagnostics?
A.No. This product is supplied For Research Use Only. It is not for diagnostic or therapeutic procedures and not for human or veterinary use.

Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.

  • Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
  • Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
  • Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
  • QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
  • Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity

To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).

Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close equivalents, or discuss custom synthesis with the right QC documentation (RUO).

LSD1 is required for euchromatic origin firing and replication timing. Signal Transduct Target Ther 2022 Apr 13;7(1):102. PMID: 35414135

Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation. Nature 2025 Jun;642(8067):508-518. PMID: 40240608

Epigenetic Remodeling Hydrogel Patches for Multidrug-Resistant Triple-Negative Breast Cancer. Adv Mater 2021 May;33(18):e2100949. PMID: 33792093

Copy number amplification of FLAD1 promotes the progression of triple-negative breast cancer through lipid metabolism. Nat Commun 2025 Feb 1;16(1):1241. PMID: 39890808

Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation. Nat Commun 2025 Jan 2;16(1):212. PMID: 39747079

Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma. Nat Commun 2021 Dec 8;12(1):7142. PMID: 34880251

Discovery of TCP-(MP)-caffeic acid analogs as a new class of agents for treatment of osteoclastic bone loss. Bioorg Chem 2024 Sep:150:107603. PMID: 38968905

Discovery of natural apigenin analogues as lysine-specific demethylase 1 inhibitors against tumoral testicular germ cells. Sci Rep 2026 Mar 2;16(1):8917. PMID: 41772063

Corin: a dual inhibitor for KDM1A/HDAC1, suppresses hepatocellular carcinoma by triggering cuproptosis. Clin Exp Med 2025 Nov 25;26(1):33. PMID: 41286164

The CBL-LSD1-CXCL8 axis regulates methionine metabolism in glioma. Cytokine 2022 Mar:151:155789. PMID: 34998158

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today